Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
D000328:Adult; D000818:Animals; D001927:Brain Diseases / Q000188:drug therapy*; D002648:Child; D004285:Dogs; D004569:Electroencephalography; D005632:Fructose / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006801:Humans; D007408:Intestinal Absorption; D007785:Lactose / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000150:complications*; D010919:Placebos; D011167:Portacaval Shunt, Surgical; D011168:Portal System / Q000503:physiopathology; D013012:Sorbitol / Q000008:administration & dosage
D010919:Placebos; D005632:Fructose; D013012:Sorbitol; D007785:Lactose